GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (TSXV:ADK) » Definitions » Cyclically Adjusted PB Ratio

Diagnos (TSXV:ADK) Cyclically Adjusted PB Ratio : (As of May. 25, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Diagnos Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Diagnos Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Diagnos's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos Cyclically Adjusted PB Ratio Chart

Diagnos Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.79 130.83 - - -

Diagnos Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Diagnos's Cyclically Adjusted PB Ratio

For the Health Information Services subindustry, Diagnos's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnos's Cyclically Adjusted PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnos's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Diagnos's Cyclically Adjusted PB Ratio falls into.


;
;

Diagnos Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Diagnos's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Diagnos's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.005/127.3637*127.3637
=-0.005

Current CPI (Dec. 2024) = 127.3637.

Diagnos Quarterly Data

Book Value per Share CPI Adj_Book
201503 -0.021 99.789 -0.027
201506 -0.082 100.500 -0.104
201509 -0.118 100.421 -0.150
201512 -0.186 99.947 -0.237
201603 -0.297 101.054 -0.374
201606 -0.335 102.002 -0.418
201609 -0.264 101.765 -0.330
201612 -0.193 101.449 -0.242
201703 -0.195 102.634 -0.242
201706 -0.090 103.029 -0.111
201709 -0.136 103.345 -0.168
201712 -0.138 103.345 -0.170
201803 -0.211 105.004 -0.256
201806 -0.265 105.557 -0.320
201809 -0.303 105.636 -0.365
201812 -0.204 105.399 -0.247
201903 -0.239 106.979 -0.285
201906 0.000 107.690 0.000
201909 0.001 107.611 0.001
201912 -0.009 107.769 -0.011
202003 0.030 107.927 0.035
202006 0.022 108.401 0.026
202009 0.016 108.164 0.019
202012 0.018 108.559 0.021
202103 0.017 110.298 0.020
202106 0.015 111.720 0.017
202109 0.010 112.905 0.011
202112 0.003 113.774 0.003
202203 -0.002 117.646 -0.002
202206 -0.011 120.806 -0.012
202209 -0.017 120.648 -0.018
202212 -0.022 120.964 -0.023
202303 -0.028 122.702 -0.029
202306 -0.032 124.203 -0.033
202309 -0.038 125.230 -0.039
202312 -0.039 125.072 -0.040
202403 -0.040 126.258 -0.040
202406 -0.030 127.522 -0.030
202409 -0.010 127.285 -0.010
202412 -0.005 127.364 -0.005

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Diagnos  (TSXV:ADK) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Diagnos Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Diagnos's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnos Business Description

Traded in Other Exchanges
Address
7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.
Executives
Tristram Coffin 10% Security Holder
Marc-andré Massue Senior Officer
Robert Dunn Director
Francis Bellido Director
Vincent Duhamel Director
André Larente Director, Senior Officer
Guillermo Moreno Robles Senior Officer
Georges Hébert Director
Gestion Maurice Pinsonnault Inc. 10% Security Holder

Diagnos Headlines

No Headlines